-- Preview Email Newsletter
| Journals Medical Newsletter for 2026-06-30 ( 10 items ) |
|
AACR Names Matthew Vander Heiden, MD, PhD, FAACR, as Editor-in-Chief of the Journal Cancer Discovery (10)
PHILADELPHIA, Pennsylvania, June 29 [Category: Medical] -- The American Association for Cancer Research posted the following news release:
* * *
AACR Names Matthew Vander Heiden, MD, PhD, FAACR, as Editor-in-Chief of the Journal Cancer Discovery
*
PHILADELPHIA - The American Association for Cancer Research (AACR) today announced the appointment of Matthew Vander Heiden, MD, PhD, Fellow of the AACR Academy (FAACR), as editor-in-chief of Cancer Discovery, one of the 10 highly esteemed journals published by AACR. Vander Heiden will serve as ed more PR
Christine Selby Co-authors New Academic Paper Following Recent Publication of Latest Book (10)
AMHERST, Massachusetts, June 29 -- The University of Massachusetts posted the following news:
* * *
Christine Selby Co-authors New Academic Paper Following Recent Publication of Latest Book
*
Christine Selby, staff psychologist in the Center for Counseling and Psychological Health (CCPH), has co-authored a new article, " Improving Early Detection of Eating Disorder Risk Among Athletes: Practical Strategies for Nonspecialist Health Providers," which was published online ahead of print by the Journal of Clinical Sport Psychology in May. The p more PR
Efzimfotase Alfa Demonstrated Improvements in Bone Health in Treatment-Naive Pediatric Patients With Hypophosphatasia Achieving Median Difference of 1.67 vs. Placebo in RGI-C Score at Week 25 in MULBERRY Phase III Trial (10)
WILMINGTON, Delaware, June 30 -- AstraZeneca, a biopharmaceutical company, issued the following news release:
* * *
Efzimfotase alfa demonstrated improvements in bone health in treatment-naIve pediatric patients with hypophosphatasia achieving median difference of 1.67 vs placebo in RGI-C Score at week 25 in MULBERRY Phase III trial
Efzimfotase alfa demonstrated favorable safety profile and tolerability in treatment -naive patients and those switching from STRENSIQ(R) across largest Phase III clinical program in HPP including MULBERRY, CHEST more PR
Global experts update heart failure definition to improve prevention, diagnosis and care (10)
DALLAS, Texas, June 29 [Category: Health Care] -- The American Heart Association posted the following news release:
* * *
Global experts update heart failure definition to improve prevention, diagnosis and care
A new international expert consensus document refines and updates how heart failure is identified and classified, aiming to improve prevention, diagnosis and management of heart failure worldwide. According to estimates from global health data, more than 64 million adults globally currently have heart failure. Heart failure continues more PR
Justice Dept. Issues Letter to to Law Firm Arnall Golden Gregory (10)
WASHINGTON, June 29 (TNSletter) -- The U.S. Department of Justice issued the following letter to Arnall Golden Gregory LLP:
* * *
Here is the text of the letter:
June 10, 2026
Brian Stimson
Arnall Golden Gregory LLP
2100 Pennsylvania Avenue, NW
Suite 350S
Washington, DC 20037
Re: United States' Title VI Inquiry Findings
Dear Mr. Stimson:
We write to notify you ofthe findings ofthe U.S. Department ofJustice (the "Department") after its investigation to determine whether the admissions practices of the University of California, Davis S more PR
London Institute of Cancer Research: Clinical Trial Design Could Improve Dose Selection, Maximising Treatment Efficacy and Safety (10)
LONDON, England, June 29 (TNSjou) -- The Institute of Cancer Research issued the following news:
* * *
New clinical trial design could improve dose selection, maximising treatment efficacy and safety
Researchers have developed a new approach to help determine the optimal dose of cancer drugs, aiming to make early-stage clinical trials more transparent and better aligned with patient needs.
Led by The Institute of Cancer Research, London, the study introduces a statistical method called WIN-DOSE, which is designed to support clearer and more more PR
Manhattan Institute Issues Commentary to Daily Wire: Are Defenders Bending the Transgender Numbers? (10)
NEW YORK, June 30 -- The Manhattan Institute issued the following excerpts of a commentary on June 28, 2026, by fellow Colin Wright to the Daily Wire:
* * *
Are Defenders Bending the Transgender Numbers?
A new Oregon study should raise concerns about the prevalence of transitioning minors.
-
For years, we were told not to worry about pediatric gender medicine because it was vanishingly rare. Puberty blockers and cross-sex hormones, we were assured, were reserved for a tiny number of carefully assessed children with severe and persistent di more PR
Michigan Medicine: Rogel Research Team Receives $3.2M Grant to Cascade Genetic Testing to Relatives (10)
ANN ARBOR, Michigan, June 30 (TNSjou) -- Michigan Medicine, the academic medical center of the University of Michigan, issued the following news release:
* * *
Rogel research team receives $3. 2 M grant to cascade genetic testing to relatives
A team of researchers based at the University of Michigan Rogel Cancer Center and Stanford University received $3.2 million from the National Cancer Institute for a clinical trial to help patients with a hereditary-based cancer diagnosis extend genetic testing to at-risk relatives.
The project is led b more PR
New Findings Could Help Prevent Strokes in Young People (10)
CHARLOTTESVILLE, Virginia, June 29 -- University of Virginia Health posted the following news release:
* * *
New Findings Could Help Prevent Strokes in Young People
*
UVA Health stroke researchers have identified a distinct and temporary pattern of gene behavior during cervical artery dissections, a leading cause of stroke in young people. These unusual gene changes may help explain the dissections and could lead to new ways to prevent potentially debilitating strokes among the young.
Finding ways to prevent cervical artery dissections is more PR
Two Longtime Georgetown University Medical Center Faculty Leaders Move to Emeritus Roles (10)
WASHINGTON, June 26 -- The Georgetown University Medical Center issued the following news:
* * *
Two Longtime Georgetown Faculty Leaders Move to Emeritus Roles
Two longtime Georgetown University Medical Center faculty leaders -- Phyllis R. Magrab, PhD, and Richard Schlegel, MD, PhD -- are moving to emeritus roles after careers that have left an outsized imprint on the institution and the world.
Together, they have contributed nearly 100 years to Georgetown, training generations of researchers and clinicians and producing scholarship with re more PR
|
